Clinical Trials Browser

Phase 2/3 × Hizentra × Other hematologic neoplasm × Clear all

NCT03730129 2020-08-26

Humoral Immunodeficiency in CLL and Therapy With Subcutaneous Ig

Phase 2/3 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell